Invest Now
Products +
Pricing
Trading & Investing +
Calculators +
Support +
Learn +
IPO +
Partner
About us +
#AndekhaSach New
Login Open an account
Samco securities limited
Samco Star Rating Ads

Samrat Pharmachem Ltd Share/Stock Price

₹ 0 (%)

Updated on 01-01-1970 5:30 AM

Stock Rating

Pros 3

 

Cons 7

Samrat Pharmachem Ltd Price Performance

  • Day's Low
  • ₹0
  • Day's High
  • ₹0
₹ 0
  • 52-w low
  • ₹0
  • 52-w high
  • ₹0
0
  • Day's open
    ₹0
  • Previous close
    ₹0
  • VWAP
    ₹0
  • Lower price band
    ₹0
  • Upper price band
    ₹0

Today's Market Action

Its last traded stock price on BSE was 465.10 down by -0.18%. The total volume of shares on NSE and BSE combined was 0 shares. Its total combined turnover was Rs 0.00 crores.

Samrat Pharmachem Ltd Medium and Long Term Market Action

The stock price of Samrat Pharmachem Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Samrat Pharmachem Ltd Fundamentals

  • Market Cap (Cr): 145

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Samrat Pharmachem Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Samrat Pharmachem Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Samrat Pharmachem Ltd

Data not available.

Samrat Pharmachem Ltd FAQ's

What is Share Price of Samrat Pharmachem Ltd?

What is the Market Cap of Samrat Pharmachem Ltd?

What is PE Ratio of Samrat Pharmachem Ltd?

What is PB Ratio of Samrat Pharmachem Ltd?

What is the CAGR of Samrat Pharmachem Ltd?

How to Buy Samrat Pharmachem Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 180.00% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
  • Asset Light Business
    The company operates a great asset light business with a high Asset turnover ratio of 24.36. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.

Cons

  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 2.00 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Poor Capital Allocation
    The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 88.52 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 123 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • Poor Corporate Governance
    The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(17/11/2024)
Stock Valuation
Green line
99
100.00%
100.00% People are bullish about Samrat Pharmachem Ltd
0.00%
0.00 % People are bearish about Samrat Pharmachem Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Samrat Pharmachem Ltd

₹ 0 (%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon
      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91